Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017).

Liu AY, Norwood A, Gundacker H, Carballo-Diéguez A, Johnson S, Patterson K, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Mayer KH, Zorrilla C, Buchbinder S, Piper JM, Lama JR, Cranston RD.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):516-520. doi: 10.1097/QAI.0000000000002066.

PMID:
31299013
2.

Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.

Chappell CA, Harkoo I, Szydlo DW, Bunge KE, Singh D, Nakabiito C, Mhlanga F, Kamira B, Piper JM, Balkus JE, Hillier SL; CAT and MTN-020/ASPIRE Study Team.

Contraception. 2019 Sep;100(3):214-218. doi: 10.1016/j.contraception.2019.06.006. Epub 2019 Jun 19.

PMID:
31226323
3.

Pharmacokinetics of Dapivirine Transfer into Blood Plasma, Breast Milk, and Cervicovaginal Fluid of Lactating Women Using the Dapivirine Vaginal Ring.

Noguchi LM, Hoesley C, Kelly C, Scheckter R, Bunge K, Nel A, Marzinke MA, Hendrix CW, Dezzutti CS, Hillier SL, Bogen DL, Piper JM, Beigi RH.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01930-18. doi: 10.1128/AAC.01930-18. Print 2019 Mar.

4.

Prevalence and determinants of anal human papillomavirus infection in men who have sex with men and transgender women.

Cranston RD, Carballo-Diéguez A, Gundacker H, Richardson BA, Giguere R, Dolezal C, Siegel A, KunjaraNaAyudhya RP, Gomez K, Piper JM, Lama JR, McGowan I; MTN-017 Protocol Team.

Int J STD AIDS. 2019 Feb;30(2):154-162. doi: 10.1177/0956462418797864. Epub 2018 Oct 18.

5.

Trajectory of use over time of an oral tablet and a rectal gel for HIV prevention among transgender women and men who have sex with men.

Leu CS, Giguere R, Bauermeister JA, Dolezal C, Brown W 3rd, Balán IC, Richardson BA, Piper JM, Lama JR, Cranston RD, Carballo-Diéguez A.

AIDS Care. 2019 Mar;31(3):379-387. doi: 10.1080/09540121.2018.1533223. Epub 2018 Oct 14.

PMID:
30318905
6.

Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048.

Liu AY, Zhang J, Anderson PL, Wagner T, Pan Z, Peda M, Gomez K, Beamer M, Jacobson C, Strizki J, Dezzutti CS, Piper JM; MTN-028 Protocol Team for the Microbicide Trials Network.

Clin Infect Dis. 2019 Mar 19;68(7):1129-1135. doi: 10.1093/cid/ciy652.

PMID:
30289444
7.

Pharmacokinetics and Pharmacodynamics of Tenofovir Reduced-Glycerin 1% Gel in the Rectal and Vaginal Compartments in Women: A Cross-Compartmental Study With Directly Observed Dosing.

Justman JE, Nair GL, Hendrix CW, Piper JM, Marzinke MA, Dai JY, Pan Z, Galaska B, Levy L, Schwartz JL, Balar B, Kunjara Na Ayudhya RP, Mushamiri I, McGowan I, Dezzutti CS; MTN-014 Study Team.

J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):175-182. doi: 10.1097/QAI.0000000000001655.

8.

Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.

Carballo-Diéguez A, Giguere R, Dolezal C, Leu CS, Balán IC, Brown W 3rd, Rael C, Richardson BA, Piper JM, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Liu A, Mayer KH, Zorrilla CD, Lama JR, McGowan I, Cranston RD; MTN-017 Protocol Team.

AIDS Behav. 2017 Dec;21(12):3336-3345. doi: 10.1007/s10461-017-1969-1.

9.

Brief Participant-Centered Convergence Interviews Integrate Self-Reports, Product Returns, and Pharmacokinetic Results to Improve Adherence Measurement in MTN-017.

Balán IC, Giguere R, Brown W 3rd, Carballo-Diéguez A, Horn S, Hendrix CW, Marzinke MA, Ayudhya RPKN, Patterson K, Piper JM, McGowan I, Lama JR, Cranston RD; MTN-017 Protocol Team.

AIDS Behav. 2018 Mar;22(3):986-995. doi: 10.1007/s10461-017-1955-7.

10.

High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women.

Carballo-Diéguez A, Balán IC, Brown W 3rd, Giguere R, Dolezal C, Leu CS, Marzinke MA, Hendrix CW, Piper JM, Richardson BA, Grossman C, Johnson S, Gomez K, Horn S, Kunjara Na Ayudhya RP, Patterson K, Jacobson C, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Liu A, Mayer KH, Zorrilla C, Lama J, McGowan I, Cranston RD.

PLoS One. 2017 Jul 27;12(7):e0181607. doi: 10.1371/journal.pone.0181607. eCollection 2017.

11.

Risk Factors for Incidence of Sexually Transmitted Infections Among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003).

Chirenje ZM, Gundacker HM, Richardson B, Rabe L, Gaffoor Z, Nair GL, Mirembe BG, Piper JM, Hillier S, Marrazzo J.

Sex Transm Dis. 2017 Mar;44(3):135-140. doi: 10.1097/OLQ.0000000000000568.

12.

MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel.

Cranston RD, Lama JR, Richardson BA, Carballo-Diéguez A, Kunjara Na Ayudhya RP, Liu K, Patterson KB, Leu CS, Galaska B, Jacobson CE, Parikh UM, Marzinke MA, Hendrix CW, Johnson S, Piper JM, Grossman C, Ho KS, Lucas J, Pickett J, Bekker LG, Chariyalertsak S, Chitwarakorn A, Gonzales P, Holtz TH, Liu AY, Mayer KH, Zorrilla C, Schwartz JL, Rooney J, McGowan I; MTN-017 Protocol Team.

Clin Infect Dis. 2017 Mar 1;64(5):614-620. doi: 10.1093/cid/ciw832.

13.

A randomized safety and pharmacokinetic trial of daily tenofovir 1% gel in term and near-term pregnancy.

Beigi RH, Noguchi LM, Montgomery E, Biggio J, Hendrix CW, Marzinke MA, Dai JY, Pan J, Kunjara Na Ayudhya R, Schwartz JL, Isaacs K, Piper JM, Watts DH.

J Int AIDS Soc. 2016 Sep 21;19(1):20990. doi: 10.7448/IAS.19.1.20990. eCollection 2016.

14.

Detectable Tenofovir Levels in Breast-Feeding Infants of Mothers Exposed to Topical Tenofovir.

Noguchi LM, Montgomery ET, Biggio JR, Hendrix CW, Bogen DL, Hillier SL, Dai JY, Piper JM, Marzinke MA, Dezzutti CS, Isaacs SK, Schwartz JL, Watts DH, Beigi RH.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5616-9. doi: 10.1128/AAC.00645-16. Print 2016 Sep.

15.

Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study.

van der Straten A, Brown ER, Marrazzo JM, Chirenje MZ, Liu K, Gomez K, Marzinke MA, Piper JM, Hendrix CW; MTN-003 VOICE Protocol Team for Microbicide Trials Network.

J Int AIDS Soc. 2016 Feb 4;19(1):20642. doi: 10.7448/IAS.19.1.20642. eCollection 2016.

16.

Impact of Sex on the Pharmacokinetics and Pharmacodynamics of 1% Tenofovir Gel.

Herold BC, Chen BA, Salata RA, Marzinke MA, Kelly CW, Dezzutti CS, McGowan I, Galaska B, Levy L, Piper JM, Hillier S, Hendrix CW.

Clin Infect Dis. 2016 Feb 1;62(3):375-382. doi: 10.1093/cid/civ913. Epub 2015 Oct 27.

17.

Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.

Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje ZM, Bunge K, Ramjee G, Nair G, Palanee-Phillips T, Selepe P, van der Straten A, Parikh UM, Gomez K, Piper JM, Watts DH, Marrazzo JM; VOICE Study Team.

Lancet HIV. 2015 Jul;2(7):e279-87.

18.

Factors associated with bone mineral density in healthy African women.

Mgodi NM, Kelly C, Gati B, Greenspan S, Dai JY, Bragg V, Livant E, Piper JM, Nakabiito C, Magure T, Marrazzo JM, Chirenje ZM, Riddler SA; MTN-003B Protocol Team.

Arch Osteoporos. 2015;10:206. doi: 10.1007/s11657-015-0206-7. Epub 2015 Feb 14.

19.

The use of a laser-level paralleling device for the fabrication of a unilateral auricular prosthesis.

Piper JM 2nd, Sutton AJ, Hansen NA.

J Prosthet Dent. 2014 May;111(5):437-9. doi: 10.1016/j.prosdent.2013.09.026. Epub 2014 Jan 17.

PMID:
24445026
20.

Novel magnet-retained prosthetic system for facial reconstruction.

Ahmed MM, Piper JM, Hansen NA, Sutton AJ, Schmalbach CE.

JAMA Facial Plast Surg. 2014 Jan-Feb;16(1):55-7. doi: 10.1001/jamafacial.2013.1760.

PMID:
24177286
21.

Treatment options for the replacement of missing mandibular incisors.

Fleigel JD 3rd, Salmon CA, Piper JM 2nd.

J Prosthodont. 2011 Jul;20(5):414-20. doi: 10.1111/j.1532-849X.2011.00732.x. Epub 2011 Jun 1.

PMID:
21631631
22.

Effect of acculturation on the acceptability of potential microbicides and sexual risk-taking.

Thurman AR, Holden AE, Shain RN, Perdue S, Piper JM.

Sex Transm Dis. 2009 Jun;36(6):387-94. doi: 10.1097/OLQ.0b013e318198d90c.

23.

Prevention of sexually transmitted infections in women.

Piper JM.

Infect Dis Clin North Am. 2008 Dec;22(4):619-635. doi: 10.1016/j.idc.2008.05.003. Review.

24.

Mitigation, adaptation, and the threat to biodiversity.

Paterson JS, Araújo MB, Berry PM, Piper JM, Rounsevell MD.

Conserv Biol. 2008 Oct;22(5):1352-5. doi: 10.1111/j.1523-1739.2008.01042.x. Epub 2008 Sep 4. No abstract available.

PMID:
18778266
25.

The influence of depression on sexual risk reduction and STD infection in a controlled, randomized intervention trial.

Holden AE, Shain RN, Miller WB, Piper JM, Perdue ST, Thurman AR, Korte JE.

Sex Transm Dis. 2008 Oct;35(10):898-904. doi: 10.1097/OLQ.0b013e31817d7a33.

26.

Preventing recurrent sexually transmitted diseases in minority adolescents: a randomized controlled trial.

Thurman AR, Holden AE, Shain RN, Perdue S, Piper JM.

Obstet Gynecol. 2008 Jun;111(6):1417-25. doi: 10.1097/AOG.0b013e318177143a.

PMID:
18515527
27.

Behavioural interventions and abuse: secondary analysis of reinfection in minority women.

Champion JD.

Int J STD AIDS. 2007 Nov;18(11):748-53. Erratum in: Int J STD AIDS. 2008 Jun;19(6):429. Shain, Rochelle N [removed]; Korte, Jeffrey E [removed]; Holden, Alan E C [removed]; Piper, Jeanna M [removed]; Perdue, Sondra T [removed]; Guerra, Fernando A [removed].

PMID:
18005508
28.

Partner notification of sexually transmitted infections: a large cohort of Mexican American and African American women.

Thurman AR, Shain RN, Holden AE, Champion JD, Perdue ST, Piper JM.

Sex Transm Dis. 2008 Feb;35(2):136-40.

PMID:
17898679
29.

Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium.

Korte JE, Baseman JB, Cagle MP, Herrera C, Piper JM, Holden AE, Perdue ST, Champion JD, Shain RN.

Am J Reprod Immunol. 2006 Apr;55(4):265-75.

PMID:
16533338
30.
31.

Relationship of abuse and pelvic inflammatory disease risk behavior in minority adolescents.

Champion JD, Piper JM, Holden AE, Shain RN, Perdue S, Korte JE.

J Am Acad Nurse Pract. 2005 Jun;17(6):234-41.

PMID:
15924566
32.

Risk and protective behaviours of bisexual minority women: a qualitative analysis.

Champion JD, Wilford K, Shain RN, Piper JM.

Int Nurs Rev. 2005 Jun;52(2):115-22.

PMID:
15842324
33.

Development of composite symptom variables for quantitative analysis of genitourinary symptomatology in women.

Piper JM, Korte JE, Holden AE, Shain RN, Perdue S, Champion JD, Newton ER.

Int J STD AIDS. 2005 Feb;16(2):128-32.

PMID:
15807940
34.

Homeostatic regulation of zinc transporters in the human small intestine by dietary zinc supplementation.

Cragg RA, Phillips SR, Piper JM, Varma JS, Campbell FC, Mathers JC, Ford D.

Gut. 2005 Apr;54(4):469-78.

35.

Human antibody responses to a Chlamydia-secreted protease factor.

Sharma J, Bosnic AM, Piper JM, Zhong G.

Infect Immun. 2004 Dec;72(12):7164-71.

36.

Rural Mexican-American adolescent sexual risk behavior.

Champion JD, Kelly P, Shain RN, Piper JM.

J Rural Health. 2004 Summer;20(3):279-85.

PMID:
15298104
37.

Prevention of gonorrhea and Chlamydia through behavioral intervention: results of a two-year controlled randomized trial in minority women.

Shain RN, Piper JM, Holden AE, Champion JD, Perdue ST, Korte JE, Guerra FA.

Sex Transm Dis. 2004 Jul;31(7):401-8.

PMID:
15215694
38.

Reduction in sexual risk behaviors and infection rates among African Americans and Mexican Americans.

Korte JE, Shain RN, Holden AE, Piper JM, Perdue ST, Champion JD, Sterneckert K.

Sex Transm Dis. 2004 Mar;31(3):166-73.

PMID:
15076930
39.

Behavioral interventions for prevention of sexually transmitted diseases in women: a physician's perspective.

Piper JM, Shain RN, Korte JE, Holden AE.

Obstet Gynecol Clin North Am. 2003 Dec;30(4):659-69.

PMID:
14719843
40.

Diagnostic assessment of Mycoplasma genitalium in culture-positive women.

Baseman JB, Cagle M, Korte JE, Herrera C, Rasmussen WG, Baseman JG, Shain R, Piper JM.

J Clin Microbiol. 2004 Jan;42(1):203-11.

41.

Behaviors changed by intervention are associated with reduced STD recurrence: the importance of context in measurement.

Shain RN, Perdue ST, Piper JM, Holden AE, Champion JD, Newton ER, Korte JE.

Sex Transm Dis. 2002 Sep;29(9):520-9.

PMID:
12218843
42.

Lung maturation in diabetes in pregnancy: if and when to test.

Piper JM.

Semin Perinatol. 2002 Jun;26(3):206-9. Review.

PMID:
12099310
43.

Interferon therapy in primary care.

Piper JM, Wen TT, Xenakis EM.

Prim Care Update Ob Gyns. 2001 Jul;8(4):163-169.

PMID:
11435124
44.
45.

Predictors of the vaginal microflora.

Newton ER, Piper JM, Shain RN, Perdue ST, Peairs W.

Am J Obstet Gynecol. 2001 Apr;184(5):845-53; discussion 853-5.

PMID:
11303191
46.

Perinatal cytomegalovirus and toxoplasmosis: challenges of antepartum therapy.

Piper JM, Wen TS.

Clin Obstet Gynecol. 1999 Mar;42(1):81-96; quiz 174-5. Review. No abstract available.

PMID:
10073303
47.

Group B streptococcus infection rate unchanged by gestational diabetes.

Piper JM, Georgiou S, Xenakis EM, Langer O.

Obstet Gynecol. 1999 Feb;93(2):292-6.

PMID:
9932572
48.

A randomized, controlled trial of a behavioral intervention to prevent sexually transmitted disease among minority women.

Shain RN, Piper JM, Newton ER, Perdue ST, Ramos R, Champion JD, Guerra FA.

N Engl J Med. 1999 Jan 14;340(2):93-100.

49.

Delayed appearance of pulmonary maturation markers is associated with poor glucose control in diabetic pregnancies.

Piper JM, Xenakis EM, Langer O.

J Matern Fetal Med. 1998 May-Jun;7(3):148-53.

PMID:
9642613
50.

Meconium: a marker for peripartum infection.

Piper JM, Newton ER, Berkus MD, Peairs WA.

Obstet Gynecol. 1998 May;91(5 Pt 1):741-5.

PMID:
9572222

Supplemental Content

Loading ...
Support Center